ARKG vs IEFA
ARK Genomic Revolution ETF vs iShares Core MSCI EAFE ETF
- • IEFA has the lower expense ratio at 0.07% vs 0.75% for ARKG.
- • IEFA pays a higher dividend yield (3.32%).
Side-by-side metrics
| Metric | ARKG | IEFA |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.07% |
Dividend yield Trailing 12-month yield. | 0.00% | 3.32% |
AUM Assets under management — bigger funds are typically more liquid. | $1.24B | $180.74B |
YTD return | 7.21% | 9.46% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.35 | 0.91 |
P/E ratio | — | 18.11 |
Last price | $30.38 | $96.28 |
Inception | — | — |
Issuer | ARK | iShares |
ARKG top holdings
| TEM | Tempus AI Inc Class A common stock | 9.45% |
| TWST | Twist Bioscience Corp | 9.02% |
| CRSP | CRISPR Therapeutics AG | 8.94% |
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 5.78% |
| BEAM | Beam Therapeutics Inc | 5.44% |
| ABSI | Absci Corp | 4.79% |
| NTRA | Natera Inc | 4.08% |
| ILMN | Illumina Inc | 4.04% |
| NTLA | Intellia Therapeutics Inc | 3.83% |
| PSNL | Personalis Inc | 3.59% |
IEFA top holdings
| ASML.AS | ASML Holding NV | 2.17% |
| HSBA.L | HSBC Holdings PLC | 1.24% |
| AZN.L | AstraZeneca PLC | 1.15% |
| ROP.SW | Roche Holding AG Ordinary Shares new | 1.13% |
| NOVN.SW | Novartis AG Registered Shares | 1.09% |
| NESN.SW | Nestle SA | 1.04% |
| SHEL.L | Shell PLC | 1.01% |
| SIE.DE | Siemens AG | 0.88% |
| CBA.AX | Commonwealth Bank of Australia | 0.83% |
| 8306.T | Mitsubishi UFJ Financial Group Inc | 0.81% |
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $1.2B in assets under management, an expense ratio of 0.75%. Its largest holding is Tempus AI Inc Class A common stock (TEM), which represents 9.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About IEFA
IEFA (iShares Core MSCI EAFE ETF) is Developed-market equities ex-US/Canada. Managed by iShares, the fund carries $180.7B in assets under management, an expense ratio of 0.07%, a dividend yield of 3.32%. Its largest holding is ASML Holding NV (ASML.AS), which represents 2.2% of the portfolio. Real Estate is the fund's largest sector exposure at 3.1%.